BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26283478)

  • 1. Antimony-Resistant Leishmania donovani Exploits miR-466i To Deactivate Host MyD88 for Regulating IL-10/IL-12 Levels during Early Hours of Infection.
    Mukherjee B; Paul J; Mukherjee S; Mukhopadhyay R; Das S; Naskar K; Sundar S; Dujardin JC; Saha B; Roy S
    J Immunol; 2015 Sep; 195(6):2731-42. PubMed ID: 26283478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.
    Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S
    J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1.
    Mukherjee B; Mukhopadhyay R; Bannerjee B; Chowdhury S; Mukherjee S; Naskar K; Allam US; Chakravortty D; Sundar S; Dujardin JC; Roy S
    Proc Natl Acad Sci U S A; 2013 Feb; 110(7):E575-82. PubMed ID: 23341611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.
    Haldar AK; Yadav V; Singhal E; Bisht KK; Singh A; Bhaumik S; Basu R; Sen P; Roy S
    PLoS Pathog; 2010 May; 6(5):e1000907. PubMed ID: 20502630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4-mediated activation of MyD88 signaling induces protective immune response and IL-10 down-regulation in Leishmania donovani infection.
    Paul J; Naskar K; Chowdhury S; Alam MN; Chakraborti T; De T
    Indian J Biochem Biophys; 2014 Dec; 51(6):531-41. PubMed ID: 25823227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune response.
    Guha R; Das S; Ghosh J; Sundar S; Dujardin JC; Roy S
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2995. PubMed ID: 25032977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant
    Mukherjee S; Pradhan S; Ghosh S; Sundar S; Das S; Mukherjee B; Roy S
    Front Cell Infect Microbiol; 2020; 10():595415. PubMed ID: 33240825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-optimal dose of Sodium Antimony Gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-gamma to IL-10 ratio.
    Haldar AK; Banerjee S; Naskar K; Kalita D; Islam NS; Roy S
    Exp Parasitol; 2009 Jun; 122(2):145-54. PubMed ID: 19422069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the molecular mechanism of aggressive infection by antimony resistant Leishmania donovani.
    Mukherjee B; Mukherjee K; Nanda P; Mukhopadhayay R; Ravichandiran V; Bhattacharyya SN; Roy S
    Cytokine; 2021 Sep; 145():155245. PubMed ID: 32861564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRAK-M regulates the inhibition of TLR-mediated macrophage immune response during late in vitro Leishmania donovani infection.
    Srivastav S; Saha A; Barua J; Ukil A; Das PK
    Eur J Immunol; 2015 Oct; 45(10):2787-97. PubMed ID: 26140693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages.
    Flandin JF; Chano F; Descoteaux A
    Eur J Immunol; 2006 Feb; 36(2):411-20. PubMed ID: 16369915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response.
    Gupta P; Giri J; Srivastav S; Chande AG; Mukhopadhyaya R; Das PK; Ukil A
    FASEB J; 2014 Apr; 28(4):1756-68. PubMed ID: 24391131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
    Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
    J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Parmar N; Chandrakar P; Vishwakarma P; Singh K; Mitra K; Kar S
    J Immunol; 2018 Aug; 201(3):957-970. PubMed ID: 29907707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 6 senses Mycobacterium avium and is required for efficient control of mycobacterial infection.
    Marinho FA; de Paula RR; Mendes AC; de Almeida LA; Gomes MT; Carvalho NB; Oliveira FS; Caliari MV; Oliveira SC
    Eur J Immunol; 2013 Sep; 43(9):2373-85. PubMed ID: 23716075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a Signaling Promotes Host Defense against
    Chakraborty A; Kurati SP; Mahata SK; Sundar S; Roy S; Sen M
    J Immunol; 2017 Aug; 199(3):992-1002. PubMed ID: 28659356
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
    Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S
    Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response.
    Srivastav S; Kar S; Chande AG; Mukhopadhyaya R; Das PK
    J Immunol; 2012 Jul; 189(2):924-34. PubMed ID: 22685311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
    Paul J; Karmakar S; De T
    Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.